Home/ADC Therapeutics/Kimberly Pope
KP

Kimberly Pope

Senior Vice President, Human Resources

ADC Therapeutics

Therapeutic Areas

ADC Therapeutics Pipeline

DrugIndicationPhase
ZYNLONTA® (loncastuximab tesirine-lpyl)Relapsed/Refractory DLBCLApproved
ZYNLONTA® combinationsEarlier lines of DLBCLPhase 3
ZYNLONTA®Indolent Non-Hodgkin LymphomasPhase 2
ADCT-601Advanced Solid TumorsPhase 1/2
ADCT-901Advanced Solid TumorsPhase 1